Shareholding disclosure

Basilea Pharmaceutica AG

Declared position

15.76%

Threshold

Crossed downwards

Timeline

Published

07.12.2013

Transaction

02.12.2013

Voting rights breakdown

Voting rights acquired0%

Voting rights sold15.76%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TADC400057

Beneficial owner

Basilea Pharmaceutica AG

Declared address

Basilea Pharmaceutica AG, 4005 Basel

Einräumung von Mitarbeiteroptionen gemäss Optionsplan, welche zum Erwerb von Namenaktien der Basilea Pharmaceutica AG (Basiswert, Bezugsverhältnis 1:1) oder entsprechendem Cash Settlement berechtigen.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG, Allschwil07.12.2013TADC400057

Disclosure summary

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the disposal side, published by SIX Exchange Regulation on 07.12.2013, at 15.76% of voting rights. Notice category: Single shareholder.

Disclosed position

15.76%

Voting rights sold

Voting rights acquired0%

Voting rights sold15.76%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 07.12.2013.

Publication date07.12.2013

Transaction date02.12.2013

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerBasilea Pharmaceutica AG

Declared addressBasilea Pharmaceutica AG, 4005 Basel

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold15.76%

Below threshold0%

ExchangeXSWX

Notification IDTADC400057

Commercial register

CHE-101.175.068

Registered

Zefix record

Conditions

Einräumung von Mitarbeiteroptionen gemäss Optionsplan, welche zum Erwerb von Namenaktien der Basilea Pharmaceutica AG (Basiswert, Bezugsverhältnis 1:1) oder entsprechendem Cash Settlement berechtigen.

Source: SIX Exchange Regulation · Publication date: 07.12.2013

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open